NCT06305039

Brief Summary

Cochlear implants (CIs) are devices that partially restore hearing for people with severe to profound hearing loss. This research focuses on CI users who use bilaterally implanted devices (two CIs, one on each side) and also "single-sided deafness" (SSD) CI users who use one CI together with good acoustic hearing in their opposite ear. The goal is to measure and understand the impact of large input asymmetries across the two ears. These asymmetries are common in BI-CI listeners and always present in SSD-CI users. Although most CI listeners benefit from a second source of auditory input, this project measures how these asymmetries limit speech understanding and spatial hearing. The long-term goal is countering or compensating for input asymmetries. Electrophysiological measures are used to describe the health of the auditory system. Behavioral measures are used to assess if training improves performance. CT imaging is utilized to describe the placement of the CIs.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
25mo left

Started Dec 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Dec 2023May 2028

Study Start

First participant enrolled

December 19, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 16, 2024

Completed
25 days until next milestone

First Posted

Study publicly available on registry

March 12, 2024

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2028

Last Updated

March 28, 2025

Status Verified

March 1, 2025

Enrollment Period

4.5 years

First QC Date

February 16, 2024

Last Update Submit

March 24, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Perceptual responses to sound level

    Interaural loudness mismatch is defined as the difference between the levels required to balance interaural loudness for sequential stimulation and the levels required to perceptually center a sound image in space for simultaneous stimulation. Participants will respond through pressing virtual buttons on a computer screen. Depending on the condition tested, the sounds will be delivered to one or both ears.

    Post-treatment - after at least 6 months use of a cochlear implant if CI user. After enrollment for non-implanted listeners with acoustic hearing.

  • Speech understanding in the presence of masking sounds

    Speech understanding will be assessed as the percentage of correctly identified keywords. Subjects will respond through oral report (where the responses will be scored by the experimenter) or through pressing virtual buttons on a computer screen. The speech sounds will be delivered to one or both ears in the presence of different types of masking sounds. In some cases, signal processing techniques will be used to distort the speech signals to simulate asymmetric hearing abilities.

    Post-treatment - after at least 6 months use of a cochlear implant if CI user. After enrollment for non-implanted listeners with acoustic hearing.

  • Computed-tomography scan

    A computed tomography temporal bone scan will be used to image the cochlear structures and cochlear implant electrode array located within. This scan will use a standard clinical scanner, with software updated to extend the Hounsfield range to reduce artifact from the metal contacts of the electrode array. This procedure uses radiographic processes, and therefore presents the subject with a safe but nonzero amount of radiation. The CT scan will be analyzed to provide measurements of each array's insertion depth within the cochlea (in degrees and mm), the distance to the cochlear modiolus (mm), and cochlear scalar location.

    For CI users: CT scan will be collected from existing medical records with permission or taken after study enrollment. Measurements taken after study enrollment. Not collected for non-implanted listeners with acoustic hearing.

  • Electrode impedance (transelectrode impedance matrix)

    This standard clinical measurement will apply a current to one electrode, and measure the resulting induced voltage at each of the other electrodes in the array, one at a time. This process uses low-level electrical stimulation only intended to measure the impedance of the intervening tissues and fluids of the cochlea, and is rarely even perceived by the subject.

    Post-treatment - after at least 6 months use of a cochlear implant if CI user. Not collected for non-implanted listeners with acoustic hearing.

  • Electrically evoked compound action potentials (ECAPs)

    Electrically evoked compound action potentials (ECAPs) will be measured using clinically-available software to track the growth in auditory nerve response (observed \~0.2-0.8 ms post-stimulus onset) as input level is varied from threshold to the maximal level at which the signal is comfortably loud. The slope of input-output function will be measured ( in microvolts/current unit) for each electrode along the electrode array of each cochlear implant study participant.

    Post-treatment - after at least 6 months use of a cochlear implant if CI user. Not collected for non-implanted listeners with acoustic hearing.

Secondary Outcomes (3)

  • Sound Localization

    Post-treatment - after at least 6 months use of a cochlear implant if CI user. After enrollment for non-implanted listeners with acoustic hearing.

  • Perceptual Fusion

    Post-treatment - after at least 6 months use of a cochlear implant if CI user. After enrollment for non-implanted listeners with acoustic hearing.

  • Spectrotemporal ripple sensitivity

    Post-treatment - after at least 6 months use of a cochlear implant if CI user. After enrollment for non-implanted listeners with acoustic hearing.

Study Arms (3)

Bilateral Cochlear Implant Users

EXPERIMENTAL
Diagnostic Test: Diagnostic tests of cochlear implant or acoustic hearing functionBehavioral: Targeted aural rehabilitation of the poorer performing ear

Unilateral Cochlear Implant Users with Single-Sided Deafness

EXPERIMENTAL
Diagnostic Test: Diagnostic tests of cochlear implant or acoustic hearing functionBehavioral: Targeted aural rehabilitation of the poorer performing ear

Non-Implanted Listeners with Acoustic Hearing

OTHER
Diagnostic Test: Diagnostic tests of cochlear implant or acoustic hearing function

Interventions

Because the cochlear implant participants in the study will use cochlear implant devices that they have already received as part of their standard-of-care treatment, the medical device itself is not an intervention for the purposes of this study. The intervention here will be to carry out diagnostic tests of cochlear implant or acoustic hearing function. This will include perceptual tests of sound localization, speech understanding in noise, binaural fusion, and loudness comparisons.

Bilateral Cochlear Implant UsersNon-Implanted Listeners with Acoustic HearingUnilateral Cochlear Implant Users with Single-Sided Deafness

Subjects will undergo listening practice on a tablet computer over headphones at home. For the test group, the aural rehabilitation will be targeted at the poorer ear. For the comparison control group, a sham aural rehabilitation will present speech to both ears.

Bilateral Cochlear Implant UsersUnilateral Cochlear Implant Users with Single-Sided Deafness

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • two cochlear implants
  • acquired their hearing loss during adulthood or late childhood (post-lingual onset)
  • native English speaker
  • primarily use oral language
  • at least six months of cochlear implant use
  • Sufficient corrected or uncorrected visual acuity (20/50 or better) to read large-font text

You may not qualify if:

  • people who do not use oral language will be excluded.
  • people with less than six months of device use will be excluded
  • other known disability or neurological disorder
  • women who are pregnant will be excluded from the CT portion of the study
  • people with any unaided audiometric tone-detection threshold better than 60 dB HL at standard audiometric frequencies (250-8000 Hz) in either ear will be excluded
  • For Unilateral Cochlear Implant User with Single-Sided Deafness Arm:
  • one cochlear implant in one ear and a second ear with some acoustic hearing
  • acquired their hearing loss during adulthood or late childhood (post-lingual onset)
  • native English speaker
  • primarily use oral language
  • at least six months of cochlear implant use
  • Sufficient corrected or uncorrected visual acuity (20/50 or better) to read large-font text
  • people who do not use oral language will be excluded.
  • people with less than six months of device use will be excluded
  • other known disability or neurological disorder
  • +8 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Walter Reed National Military Medical Center

Bethesda, Maryland, 20889, United States

Location

University of Maryland, College Park

College Park, Maryland, 20742, United States

Location

MeSH Terms

Conditions

Hearing LossHearing Loss, Sensorineural

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Matthew J. Goupell, PhD

    University of Maryland, College Park

    PRINCIPAL INVESTIGATOR
  • Joshua G. Bernstein, PhD

    Walter Reed National Military Medical Center; University of Maryland, College Park

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Hearing and Speech Sciences

Study Record Dates

First Submitted

February 16, 2024

First Posted

March 12, 2024

Study Start

December 19, 2023

Primary Completion (Estimated)

May 31, 2028

Study Completion (Estimated)

May 31, 2028

Last Updated

March 28, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

De-identified data that document, support, and validate research findings will be made available when the main findings have been accepted for publication. De-identified data relevant to the project will be disseminated to researchers on and off-campus by request and review of the PI. After publication, research products from this project will be archived at the Digital Repository at the University of Maryland(DRUM). DRUM is a long-term, open access repository managed and maintained by the University of Maryland Libraries. Researchers and the general public can download data and code files, associated metadata and documentation, and any guidelines for reuse.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Following publication, available for at least seven years.
Access Criteria
Investigators whose proposed use of the data has been approved by an independent review committee

Locations